| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |